Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

about

The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.Current perspectives on bone metastases in castrate-resistant prostate cancer.

P2860

Q39306297-A99C5B27-84D3-4C1A-A60A-9254F23801BC Q49285273-E24E90C0-55FA-43D8-B482-16C8B69639D8

P2860

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

Item

http://www.wikidata.org/entity/Q38995718

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Meeting Report From the Prosta ...... c Working Group on Radium-223.

@en

type

Item

label

Meeting Report From the Prosta ...... c Working Group on Radium-223.

@en

prefLabel

Meeting Report From the Prosta ...... c Working Group on Radium-223.

@en

P1476

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223

@en

P2093

Howard R Soule

http://www.w3.org/2001/XMLSchema#string

PCF Radium-223 Scientific Working Group

http://www.w3.org/2001/XMLSchema#string

P2860

Improved endpoints for cancer immunotherapy trials

Integrative clinical genomics of advanced prostate cancer.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone

Alpha emitter radium-223 and survival in metastatic prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomis

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.

A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients.

P304

245-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23272

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Morris

Andrea K. Miyahira

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27800631

http://www.w3.org/2001/XMLSchema#string

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

about

P2860

P2860

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698